95 related articles for article (PubMed ID: 24735751)
1. A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3.
Huang CY; Tai WT; Hsieh CY; Hsu WM; Lai YJ; Chen LJ; Shiau CW; Chen KF
Cancer Lett; 2014 Jul; 349(2):136-43. PubMed ID: 24735751
[TBL] [Abstract][Full Text] [Related]
2. Sorafenib analogue SC-60 induces apoptosis through the SHP-1/STAT3 pathway and enhances docetaxel cytotoxicity in triple-negative breast cancer cells.
Liu CY; Su JC; Huang TT; Chu PY; Huang CT; Wang WL; Lee CH; Lau KY; Tsai WC; Yang HP; Shiau CW; Tseng LM; Chen KF
Mol Oncol; 2017 Mar; 11(3):266-279. PubMed ID: 28084011
[TBL] [Abstract][Full Text] [Related]
3. Chemical and genetic inhibition of STAT3 sensitizes hepatocellular carcinoma cells to sorafenib induced cell death.
Xie L; Zeng Y; Dai Z; He W; Ke H; Lin Q; Chen Y; Bu J; Lin D; Zheng M
Int J Biol Sci; 2018; 14(5):577-585. PubMed ID: 29805309
[TBL] [Abstract][Full Text] [Related]
4. Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition.
Su TH; Shiau CW; Jao P; Liu CH; Liu CJ; Tai WT; Jeng YM; Yang HC; Tseng TC; Huang HP; Cheng HR; Chen PJ; Chen KF; Kao JH; Chen DS
Proc Natl Acad Sci U S A; 2015 Jun; 112(23):7243-8. PubMed ID: 26039995
[TBL] [Abstract][Full Text] [Related]
5. SKI-349, a Sphingosine Kinases 1/2 Inhibitor, Suppresses Cell Viability, Invasion, and AKT/mTOR Signaling Pathway, and Shows Synergistic Cytotoxic Effects with Sorafenib in Hepatocellular Carcinoma.
Chen L; Wang L; Han Z; Qin P; Niu G; Du J
Tohoku J Exp Med; 2024 Mar; 262(3):173-180. PubMed ID: 38123304
[TBL] [Abstract][Full Text] [Related]
6. IL-22 signaling promotes sorafenib resistance in hepatocellular carcinoma via STAT3/CD155 signaling axis.
Chen J; Sun S; Li H; Cai X; Wan C
Front Immunol; 2024; 15():1373321. PubMed ID: 38596684
[TBL] [Abstract][Full Text] [Related]
7. Leonurine ameliorates the STAT3 pathway through the upregulation of SHP-1 to retard the growth of hepatocellular carcinoma cells.
Jung YY; Kim C; Shanmugam MK; Deivasigamani A; Chinnathambi A; Alharbi SA; Rangappa KS; Hui KM; Sethi G; Mohan CD; Ahn KS
Cell Signal; 2024 Feb; 114():111003. PubMed ID: 38048857
[TBL] [Abstract][Full Text] [Related]
8. Withaferin A, a natural thioredoxin reductase 1 (TrxR1) inhibitor, synergistically enhances the antitumor efficacy of sorafenib through ROS-mediated ER stress and DNA damage in hepatocellular carcinoma cells.
Chen X; Zhu N; Wu Y; Zhang Y; Zhang Y; Jin K; Zhou Z; Chen G; Wang J
Phytomedicine; 2024 Jun; 128():155317. PubMed ID: 38537439
[TBL] [Abstract][Full Text] [Related]
9. Mechanism study of tyrosine phosphatase shp-1 in inhibiting hepatocellular carcinoma progression by regulating the SHP2/GM-CSF pathway in TAMs.
Wei Q; Luo S; He G
Sci Rep; 2024 Apr; 14(1):9128. PubMed ID: 38644382
[TBL] [Abstract][Full Text] [Related]
10. ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma.
Feng J; Lu PZ; Zhu GZ; Hooi SC; Wu Y; Huang XW; Dai HQ; Chen PH; Li ZJ; Su WJ; Han CY; Ye XP; Peng T; Zhou J; Lu GD
Acta Pharmacol Sin; 2021 Jan; 42(1):160-170. PubMed ID: 32541921
[TBL] [Abstract][Full Text] [Related]
11. Compound K Induces Endoplasmic Reticulum Stress and Apoptosis in Human Liver Cancer Cells by Regulating STAT3.
Zhang X; Zhang S; Sun Q; Jiao W; Yan Y; Zhang X
Molecules; 2018 Jun; 23(6):. PubMed ID: 29921768
[TBL] [Abstract][Full Text] [Related]
12. Targeting C21orf58 is a Novel Treatment Strategy of Hepatocellular Carcinoma by Disrupting the Formation of JAK2/C21orf58/STAT3 Complex.
Jiang H; Wang Y; Wen D; Yu R; Esa SS; Lv K; Feng Q; Liu J; Li F; He L; Di X; Zhang S
Adv Sci (Weinh); 2024 Apr; 11(15):e2306623. PubMed ID: 38342622
[TBL] [Abstract][Full Text] [Related]
13. Quetiapine Significantly Improves the Effectiveness of Radiotherapy in Combating Hepatocellular Carcinoma Progression in a Hep3B Xenograft Mouse Model.
Yang JD; Liu YC; Wang HC; Hsu FT; Liao TL; Huang MC; Chen JH
In Vivo; 2024; 38(3):1079-1093. PubMed ID: 38688627
[TBL] [Abstract][Full Text] [Related]
14. Osthole inhibits GSK-3β/AMPK/mTOR pathway-controlled glycolysis and increases radiosensitivity of subcutaneous transplanted hepatocellular carcinoma in nude mice.
Huang H; Xue J; Xie ML; Xie T
Strahlenther Onkol; 2024 May; 200(5):444-452. PubMed ID: 37963994
[TBL] [Abstract][Full Text] [Related]
15. Discovery of 2,6-Naphthyridine Analogues as Selective FGFR4 Inhibitors for Hepatocellular Carcinoma.
Oh H; Kim J; Jung SH; Ha TH; Ahn YG; Nam G; Moon K; Singh P; Kim IS
J Med Chem; 2024 May; 67(10):8445-8459. PubMed ID: 38706130
[TBL] [Abstract][Full Text] [Related]
16. The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk.
Xu C; Gao X; Ren T; Geng H; Yang K; Huang Y; Zhang W; Hou S; Song A; Zhang Y; Zhao Q
Pharmacol Res; 2024 May; 203():107142. PubMed ID: 38522759
[TBL] [Abstract][Full Text] [Related]
17. Novel STAT3 oligonucleotide compounds suppress tumor growth and overcome the acquired resistance to sorafenib in hepatocellular carcinoma.
Zhang QY; Ding W; Mo JS; Ou-Yang SM; Lin ZY; Peng KR; Liu GP; Lu JJ; Yue PB; Lei JP; Wang YD; Zhang XL
Acta Pharmacol Sin; 2024 Apr; ():. PubMed ID: 38609562
[TBL] [Abstract][Full Text] [Related]
18. Capsaicin: Effects on the Pathogenesis of Hepatocellular Carcinoma.
Scheau C; Badarau IA; Caruntu C; Mihai GL; Didilescu AC; Constantin C; Neagu M
Molecules; 2019 Jun; 24(13):. PubMed ID: 31247901
[TBL] [Abstract][Full Text] [Related]
19. Establishment of image-guided radiotherapy of orthotopic hepatocellular carcinoma mouse model.
Zhou K; Jiang Y; Feng S; Mo W; Nie J; Cao J; Jiao Y
Animal Model Exp Med; 2023 Oct; 6(5):419-426. PubMed ID: 37365733
[TBL] [Abstract][Full Text] [Related]
20. Radiosensitization by Marine Sponge Agelas sp. Extracts in Hepatocellular Carcinoma Cells with Autophagy Induction.
Choi C; Son A; Lee HS; Lee YJ; Park HC
Sci Rep; 2018 Apr; 8(1):6317. PubMed ID: 29679028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
